Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

The underlying issue for pharma companies using AI lies in the quality of the inputs and how AI models are used.

Enhanced Compliance: CMDM ensures that all HCP and HCO data is accurate and up-to-date, which is critical for meeting ...

Vanda Pharmaceuticals (VNDA) surges 20% in premarket trading after Cycle Pharmaceuticals reaffirms $8/share all cash offer in ...

Adam Wandt, an attorney and deputy chair for technology at the John Jay School of Criminal Justice, said the barrage of state ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Blackweek’s inaugural three-day conference featured several health-focused panels discussing health equity and more inclusive ...

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker ...

UK-based Cycle Pharmaceuticals on Monday reaffirmed its offer to buy Vanda Pharmaceuticals in a deal that values the US ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...